A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis
N/A
The purpose of this study is to assess whether Multiple Sclerosis patients ...
Status
Unknown
Location
MS Center at Evergreen Health
Start Date
2013-01
Trial ID
NCT01811290
Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
PHASE4
The investigators propose to perform a pragmatic, multicenter, open-label, ...